Estrogen receptor beta in breast cancer.

Estrogen is essential for normal growth and differentiation in the mammary gland. It also supports growth of approximately 50% of primary breast cancers. For this reason, removal of estrogen or blocking of its action with the anti-estrogen, tamoxifen, is the main treatment for estrogen receptor alpha (ERalpha)-positive tumors. In 1996, when oncologists became aware of a second ER, ERbeta, there was some doubt as to whether this receptor would be of importance in breast cancer because the clinical consensus was that responsiveness to tamoxifen is related to the presence of ERalpha in breast cancer. Today we know that ERalpha and ERbeta have distinct cellular distributions, regulate separate sets of genes and can oppose each other's actions on some genes. We also know that ERbeta is widely expressed in both the normal and malignant breast and that there are proliferating cells in the breast which express ERbeta. In this review we summarize what is known about ERbeta in breast cancer and examine the possibility that ERbeta-selective ligands may well represent a useful class of pharmacological tools with a novel target, namely proliferating cells expressing ERbeta.

[1]  J. Gustafsson,et al.  A Role for the Androgen Receptor in Follicular Atresia of Estrogen Receptor Beta Knockout Mouse Ovary1 , 2002, Biology of reproduction.

[2]  S. Safe,et al.  Functional synergy between the transcription factor Sp1 and the estrogen receptor. , 1997, Molecular endocrinology.

[3]  M. Lippman,et al.  Estrogen receptor determination predicts response to tamoxifen therapy. , 1980, Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer.

[4]  J. Lehmann,et al.  Cloning and characterization of human estrogen receptor beta isoforms. , 1998, Biochemical and biophysical research communications.

[5]  Y. Miyoshi,et al.  Quantitative analysis of estrogen receptor‐α and ‐β messenger RNA expression in breast carcinoma by real‐time polymerase chain reaction , 2000 .

[6]  J. Russo,et al.  Increased expression of estrogen receptor beta in chemically transformed human breast epithelial cells. , 1998, International journal of oncology.

[7]  R. Coombes,et al.  Breast Estrogen and Progesterone Receptors in the Normal Female Updated Version , 2006 .

[8]  K. Korach,et al.  Receptor null mice reveal contrasting roles for estrogen receptor α and β in reproductive tissues , 2000, The Journal of Steroid Biochemistry and Molecular Biology.

[9]  M. Lippman,et al.  Growth of a human breast cancer cell line in serum-free hormone-supplemented medium. , 1978, Cancer research.

[10]  A. Howell,et al.  Dissociation between steroid receptor expression and cell proliferation in the human breast. , 1997, Cancer research.

[11]  D. Chalbos,et al.  Estrogens stimulate cell proliferation and induce secretory proteins in a human breast cancer cell line (T47D). , 1982, The Journal of clinical endocrinology and metabolism.

[12]  S. Chu,et al.  Identification of a splice variant of the rat estrogen receptor beta gene. , 1997, Molecular and cellular endocrinology.

[13]  R. Lupu,et al.  Expression of Estrogen Receptor β Messenger RNA Variant in Breast Cancer , 1998 .

[14]  M. Kerin,et al.  Prognostic significance of oestrogen receptor beta in breast cancer. , 2000, The British journal of surgery.

[15]  S. Inoue,et al.  Clinical value of the wild-type estrogen receptor beta expression in breast cancer. , 2001, Cancer letters.

[16]  M. Duffy,et al.  Detection of Estrogen Receptor-Beta mRNA in Breast Cancer Using RT-PCR , 2000, The International journal of biological markers.

[17]  J. Gustafsson,et al.  The normal and malignant mammary gland: a fresh look with ER beta onboard. , 2000, Journal of mammary gland biology and neoplasia.

[18]  V. Jordan,et al.  Growth regulation of estrogen receptor-negative breast cancer cells transfected with complementary DNAs for estrogen receptor. , 1992, Journal of the National Cancer Institute.

[19]  V. Speirs,et al.  Prognostic significance of oestrogen receptor β in breast cancer , 2000 .

[20]  V. Jordan,et al.  Transfection of human estrogen receptor (ER) cDNA into ER-negative mammalian cell lines , 1994, The Journal of Steroid Biochemistry and Molecular Biology.

[21]  Jorma Isola,et al.  Estrogen Receptor β Is Coexpressed with ERα and PR and Associated with Nodal Status, Grade, and Proliferation Rate in Breast Cancer , 2000 .

[22]  J. Gustafsson,et al.  The Normal and Malignant Mammary Gland: A Fresh Look with ERβ Onboard , 2000, Journal of Mammary Gland Biology and Neoplasia.

[23]  R. Bernards,et al.  CDK-Independent Activation of Estrogen Receptor by Cyclin D1 , 1997, Cell.

[24]  B. O’Malley,et al.  The 26S Proteasome Is Required for Estrogen Receptor-α and Coactivator Turnover and for Efficient Estrogen Receptor-α Transactivation , 2000 .

[25]  V. Jordan,et al.  Paradoxical regulation of estrogen-dependent growth factor gene expression in estrogen receptor (ER)-negative human breast cancer cells stably expressing ER. , 1994, Cancer letters.

[26]  B. O’Malley,et al.  The 26S proteasome is required for estrogen receptor-alpha and coactivator turnover and for efficient estrogen receptor-alpha transactivation. , 2000, Molecular cell.

[27]  J. Isola,et al.  Estrogen receptor beta is coexpressed with ERalpha and PR and associated with nodal status, grade, and proliferation rate in breast cancer. , 2000, The American journal of pathology.

[28]  J. Gustafsson,et al.  Cloning of a novel receptor expressed in rat prostate and ovary. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[29]  Y. Miyoshi,et al.  Quantitative analysis of estrogen receptor-alpha and -beta messenger RNA expression in breast carcinoma by real-time polymerase chain reaction. , 2000, Cancer.

[30]  J. Gustafsson,et al.  Estrogen receptors alpha and beta in the rodent mammary gland. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[31]  J. Lakins,et al.  Expression and regulation of estrogen receptor beta in human breast tumors and cell lines. , 2000, Oncology reports.

[32]  M. Ewen,et al.  Cyclin D1 stimulation of estrogen receptor transcriptional activity independent of cdk4 , 1997, Molecular and cellular biology.

[33]  J. Gustafsson,et al.  Generation and reproductive phenotypes of mice lacking estrogen receptor beta. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[34]  G. Greene,et al.  Antibodies to estrogen receptor: immunochemical similarity of estrophilin from various mammalian species. , 1977, Proceedings of the National Academy of Sciences of the United States of America.

[35]  N. Zeps,et al.  Murine Progesterone Receptor Expression in Proliferating Mammary Epithelial Cells During Normal Pubertal Development and Adult Estrous Cycle: Association with ERα and ERβ Status , 1999, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[36]  R. Lupu,et al.  Expression of estrogen receptor beta messenger RNA variant in breast cancer. , 1998, Cancer research.

[37]  I. Ellis,et al.  A possible divergent role for the oestrogen receptor alpha and beta subtypes in clinical breast cancer , 2000, International journal of cancer.

[38]  W. McGuire,et al.  Steroid hormone receptors and carcinoma of the breast. , 1982, The American journal of physiology.

[39]  M. Kerin,et al.  Increased expression of estrogen receptor beta mRNA in tamoxifen-resistant breast cancer patients. , 1999, Cancer research.

[40]  R. Coombes,et al.  Estrogen receptors and proliferation markers in primary and recurrent breast cancer , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[41]  Z. Werb,et al.  Signaling through the stromal epidermal growth factor receptor is necessary for mammary ductal development. , 1999, Development.

[42]  Y. Ouchi,et al.  Cross‐inhibition of both estrogen receptor α and β pathways by each dominant negative mutant , 1998 .

[43]  J. Gustafsson,et al.  Quantitative Analysis of Estrogen Receptor Proteins in Rat Mammary Gland. , 2001, Endocrinology.

[44]  H. Rochefort,et al.  Antiestrogens inhibit the mitogenic effect of growth factors on breast cancer cells in the total absence of estrogens. , 1987, Biochemical and biophysical research communications.

[45]  K. Korach.  Estrogen Receptor Knock-Out Mice: Molecular and Endocrine Phenotypes , 2000, The Journal of the Society for Gynecologic Investigation: JSGI.

[46]  Y. Ouchi,et al.  Molecular cloning and characterization of human estrogen receptor βcx: A potential inhibitor of estrogen action in human , 1998 .

[47]  T. Garcia,et al.  Estrogen receptor impairs interleukin-6 expression by preventing protein binding on the NF-kappaB site. , 1997, Nucleic acids research.

[48]  J. Lehmann,et al.  Cloning and Characterization of Human Estrogen Receptor β Isoforms , 1998 .

[49]  A. Howell,et al.  Estrogen sensitivity of normal human breast tissue in vivo and implanted into athymic nude mice: Analysis of the relationship between estrogen-induced proliferation and progesterone receptor expression , 1997, Breast Cancer Research and Treatment.

[50]  S. Kato,et al.  A novel isoform of rat estrogen receptor beta with 18 amino acid insertion in the ligand binding domain as a putative dominant negative regular of estrogen action. , 1998, Biochemical and biophysical research communications.

[51]  K. Korach,et al.  Receptor null mice reveal contrasting roles for estrogen receptor alpha and beta in reproductive tissues. , 2000, The Journal of steroid biochemistry and molecular biology.

[52]  J. Gustafsson,et al.  False negatives in oestrogen-receptor assay , 2000, The Lancet.

[53]  L. Moore,et al.  Expression of wild-type estrogen receptor beta and variant isoforms in human breast cancer. , 1999, Cancer research.

[54]  B. Hulka,et al.  Breast cancer: cause and prevention , 1995, The Lancet.

[55]  R. Laucirica,et al.  Estrogen receptor beta expression in invasive breast cancer. , 2001, Human pathology.

[56]  S. Chu,et al.  Identification of a splice variant of the rat estrogen receptor β gene , 1997, Molecular and Cellular Endocrinology.

[57]  K. Korach,et al.  Estrogen receptor null mice: what have we learned and where will they lead us? , 1999, Endocrine reviews.

[58]  J. Gustafsson,et al.  Estrogen receptor β in the breast: role in estrogen responsiveness and development of breast cancer , 2000, The Journal of Steroid Biochemistry and Molecular Biology.

[59]  J. Gustafsson,et al.  Decreased expression of estrogen receptor beta protein in proliferative preinvasive mammary tumors. , 2001, Cancer research.

[60]  J. Gustafsson,et al.  Estrogen receptors α and β in the rodent mammary gland , 2000, Breast Cancer Research.

[61]  M. Yancisin,et al.  Functional analysis of a novel estrogen receptor-beta isoform. , 1999, Molecular endocrinology.

[62]  Helmut Dotzlaw,et al.  Expression of estrogen receptor-beta in human breast tumors. , 1997, The Journal of clinical endocrinology and metabolism.

[63]  Y. Ouchi,et al.  The complete primary structure of human estrogen receptor beta (hER beta) and its heterodimerization with ER alpha in vivo and in vitro. , 1998, Biochemical and biophysical research communications.

[64]  J. Gustafsson,et al.  Differential ligand activation of estrogen receptors ERalpha and ERbeta at AP1 sites. , 1997, Science.

[65]  W. Wahli,et al.  Functional Interactions between the Estrogen Receptor and the Transcription Activator Sp1 Regulate the Estrogen-dependent Transcriptional Activity of the Vitellogenin A1 ioPromoter* , 1997, The Journal of Biological Chemistry.

[66]  B. O’Malley,et al.  Molecular mechanisms of action of steroid/thyroid receptor superfamily members. , 1994, Annual review of biochemistry.

[67]  Simak Ali,et al.  Estrogen Receptor Alpha in Human Breast Cancer: Occurrence and Significance , 2000, Journal of Mammary Gland Biology and Neoplasia.

[68]  H. Rochefort,et al.  Activation of estrogen receptor transfected into a receptor-negative breast cancer cell line decreases the metastatic and invasive potential of the cells. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[69]  L. Andersson,et al.  A role for estrogen receptor β in the regulation of growth of the ventral prostate , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[70]  S. Inoue,et al.  Clinical value of the wild-type estrogen receptor β expression in breast cancer , 2001 .